Recently, next-generation sequencing (NGS) deep-sequencing data have also revealed recurrent KEAP1 and NRF2 mutations in solid tumors of the head and neck, upper digestive tract, and renal cell carcinoma [48,61]. The gene discussed is NFE2L2; the disease is renal cell carcinoma.